PMA device
Glaukos Istent Trabecular Bypass Stent Model GTS100R/L
Glaukos Corporation · Intraocular Pressure Lowering Implant (OGO, Class III) · First FDA decision Jun 25, 2012, newest Jun 25, 2012Glaucoma
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
33
Naming "Istent Trabecular Bypass"
MAUDE reports
0
Brand "Istent Trabecular Bypass", since 2015
PubMed studies
10
Mentioning "Istent Trabecular Bypass"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Glaukos Istent Trabecular Bypass Stent Model GTS100R/L
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
P080030 · Decided Jun 25, 2012 · 1,284 days after receipt
Device type: Intraocular pressure lowering implant (OGO) · Ophthalmology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Implantable Pulmonary Artery Pressure Sensors for Heart Failure ManagementNational determinationOn the books20.36Updated Oct 6, 2026
- Implantable Pulmonary Artery Pressure Sensors for Heart Failure ManagementNational analysisReview closedCAG-00466NUpdated Sep 18, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "Istent Trabecular Bypass", any status and sponsor, newest update first.
- Standalone iStent Infinite and iDose TR for Management of Moderate to Severe Open Angle GlaucomaRecruiting
Jonathon MyersAcademic, hospital or other
NCT07228221 · 20 participants (planned) · Start Jan 5, 2026 · Primary completion Aug 30, 2031
Device: iStent infinite trabecular micro-bypass system model iS3 · For: Open Angle Glaucoma; Pigmentary Glaucoma; Pseudoexfoliation Glaucoma
Sites: Philadelphia, Pennsylvania
Sight Sciences, Inc.Not on our public-company list
NCT04658095 · 10 participants · Start Jan 11, 2022 · Primary completion Nov 18, 2022
Device: Canaloplasty and trabeculotomy with the OMNI system.; iStent inject and 1 more · For: Glaucoma, Open-Angle
Sites: Frankfurt, Germany; Barcelona, Spain; Valencia, Spain · 5 sites in all
Yu-Ting TsaoAcademic, hospital or other
NCT06630546 · 71 participants · Start May 16, 2022 · Primary completion Apr 30, 2023
Device: first generation iStent (Glaukos, San Clemente, CA, USA) insertion; phacoemulsification · For: Primary Open Angle Glaucoma (POAG); Istent Inject W; Normal Tension Glaucoma (NTG)
Sites: Taoyuan City, Taiwan
30 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Istent Trabecular Bypass", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code OGO
2,634 reports: 667 malfunction, 1,967 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Istent Trabecular Bypass"[tiab]. The summary above synthesizes these.
- Standalone iStent Trabecular Micro-bypass Glaucoma Surgery: A Systematic Review and Meta-Analysis.
Healey PR, Clement CI, Kerr NM, et al. · J Glaucoma · 2021Meta-Analysis, Systematic Review
- Uveitis-Glaucoma-Hyphema Syndrome Following iStent Implantation.
Siedlecki A, Kinariwala B, Sieminski S · Case Rep Ophthalmol · 2022Case Reports
- Endophthalmitis following combined cataract extraction and placement of an iStent trabecular bypass device.
Chaves AC, Grosinger AJ, Ten Hulzen RD, et al. · Am J Ophthalmol Case Rep · 2020Case Reports
- 12-Month Retrospective Comparison of Kahook Dual Blade Excisional Goniotomy with Istent Trabecular Bypass Device Implantation in Glaucomatous Eyes at the Time of Cataract Surgery.
ElMallah MK, Seibold LK, Kahook MY, et al. · Adv Ther · 2019Research Support, Non-U.S. Gov't
- Comparison of Hydrus and iStent microinvasive glaucoma surgery implants in combination with phacoemulsification for treatment of open-angle glaucoma: systematic review and network meta-analysis.
Hu R, Guo D, Hong N, et al. · BMJ Open · 2022Systematic Review, Research Support, Non-U.S. Gov't
- Adverse events of trabecular micro-bypass minimally invasive glaucoma surgery devices: a five-year analysis from the FDA MAUDE database.
Hawas Y, Ghazou A, Gerges MW, et al. · Int Ophthalmol · 2025
- The Effectiveness of First-Generation iStent Microbypass Implantation Depends on Initial Intraocular Pressure: 24-Month Follow-Up-Prospective Clinical Trial.
Konopiska J, Kozera M, Kraśnicki P, et al. · J Ophthalmol · 2020
- Comparison of Safety and Efficacy of Hydrus and iStent Combined with Phacoemulsyfication in Open Angle Glaucoma Patients: 24-Month Follow-Up.
Jaboska J, Lewczuk K, Rwkas MT · Int J Environ Res Public Health · 2023
- Comparison of minimally invasive glaucoma surgery with trabecular micro-bypass stent and microhook ab interno trabeculotomy performed in conjunction with cataract surgery.
Tokuda N, Kitaoka Y, Tsukamoto A, et al. · Int J Ophthalmol · 2022
- A multicenter retrospective comparison of goniotomy versus trabecular bypass device implantation in glaucoma patients undergoing cataract extraction.
Dorairaj SK, Kahook MY, Williamson BK, et al. · Clin Ophthalmol · 2018
Other devices of this type
Also filed under product code OGO.
- iStent Trabecular Micro-Bypass Stent System, iStent inject Trabecular Micro-Bypass System, iStent inject W Trabecular MiGlaukos Corporation · PMA 2022
- iStent inject Trabecular MicroBypass SystemGlaukos Corporation · PMA 2025
- Hydrus MicrostentAlcon Research, LLC · PMA 2025
- iStent inject® W Trabecular Micro-Bypass System Model iS2Glaukos Corporation · PMA 2025
- CyPass System 241-SAlcon Research, Ltd. · PMA 2018
- Glaukos Trabecular Micro Bypass Stent Model GTS100R/LGlaukos Corporation · PMA 2013
- CyPass Micro-StentAlcon Research, Ltd. · PMA 2020
- iStent® Trabecular Mjcro-Bypass Stent System, Model GTS100Glaukos Corporation · PMA 2024
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.